Bipolar disorder

AF Carvalho, J Firth, E Vieta - New England Journal of Medicine, 2020 - Mass Medical Soc
Bipolar Disorder | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Bipolar disorders

E Vieta, M Berk, TG Schulze, AF Carvalho… - Nature reviews Disease …, 2018 - nature.com
Bipolar disorders are chronic and recurrent disorders that affect> 1% of the global
population. Bipolar disorders are leading causes of disability in young people as they can …

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …

LN Yatham, SH Kennedy, SV Parikh… - Bipolar …, 2018 - Wiley Online Library
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings

TG Rhee, M Olfson, AA Nierenberg… - American Journal of …, 2020 - Am Psychiatric Assoc
Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval …

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon… - World …, 2017 - Wiley Online Library
Illness staging is widely utilized in several medical disciplines to help predict course or
prognosis, and optimize treatment. Staging models in psychiatry in general, and bipolar …

Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

AT Amare, A Thalamuthu, KO Schubert… - Molecular …, 2023 - nature.com
Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and
disabling mental health disorder that affects about 1% of the population worldwide …

Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study

M Lähteenvuo, T Paljärvi, A Tanskanen… - The British Journal of …, 2023 - cambridge.org
BackgroundPharmacological treatment patterns for bipolar disorder have changed during
recent years, but for better or worse? AimsTo investigate the comparative real-world …

Challenging the negative perception of lithium and optimizing its long-term administration

JK Rybakowski - Frontiers in molecular neuroscience, 2018 - frontiersin.org
The use of lithium for the prevention of recurrences in mood disorders has a 55-year history.
Nowadays, lithium is universally accepted as the first-choice mood-stabilizer (MS) for …

Prediction of lithium response using clinical data

A Nunes, R Ardau, A Berghöfer… - Acta Psychiatrica …, 2020 - Wiley Online Library
Objective Promptly establishing maintenance therapy could reduce morbidity and mortality
in patients with bipolar disorder. Using a machine learning approach, we sought to evaluate …

Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper

G Sampogna, D Janiri, U Albert, F Caraci… - Expert Review of …, 2022 - Taylor & Francis
Introduction Lithium treatment is considered the gold standard for the long-term
management of bipolar disorder and recurrent unipolar depression. It is also extremely …